- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02112461
Hospice and End-of-life Symptom Monitoring & Support Using an Automated System Designed for Family Caregivers (SCP)
Enhancing End-of-Life and Bereavement Outcomes Among Cancer Caregivers: Symptom Care by Phone for Hospice Caregiver Support and Cancer Symptom Relief
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
Individuals dying from cancer often live out their lives at home with a host of poorly controlled symptoms. Ineffective symptom management results, in part, from inadequate monitoring of patients once they leave the treatment-focused arena of the clinical setting. The changing pattern of symptoms is challenging as care strategies and recommendations from previous encounters with healthcare providers become quickly outdated. The burden of end-of-life care largely falls to family caregivers, usually a spouse or partner, who feel enormous pressure to provide physical and supportive care but often lacks the knowledge and skill resulting in significant caregiver burden and distress that may extend into bereavement.
This prospective, clinical trial proposes to develop and test a telecommunication system, Symptom Care by Phone- Hospice that has been designed to bridge the divide between home and palliative care support for patients at the end of life and their family caregiver. SCP-Hospice has three elements: 1) daily monitoring of symptoms common at end of life, 2) automated alerting of the hospice nurse case manager about symptoms that have exceeded a pre-set threshold for symptom severity or caregiver distress about symptoms, and 3) automated, just in time, tailored care management strategies for the caregiver to implement to address the patient's symptoms. Caregivers call the SCP-Hospice system daily to report patient symptoms and then are immediately provided automated, tailored care suggestions paired to the specific symptom profile.
The specific aims of the study are to test whether the SCP-Hospice intervention reduces severity and distress from 12 different symptoms and whether it decreases caregiver burden, anxiety, depressed mood and distress about the patient's symptoms and improves caregiver sleep when compared with usual care. The mechanisms that explain how SCP-Hospice affect these outcomes also will be explored. Other aims will compare patient care strategies utilized by caregivers and evaluate caregiver and Hospice nurse satisfaction with the SCP system.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84112
- University of Utah College of Nursing
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Patient/Caregiver Dyad Inclusion Criteria:
- Both patient and caregiver are adults age 18 or over
- Patients has a limited life expectancy and has histological diagnosis of cancer
- Caregiver is caring for a family member with a limited life expectancy and admitted to one of the participating home care hospice or palliative care programs
- Caregiver is English speaking and writing
- Caregiver has access to a telephone on a daily basis
- Caregiver is cognitively and physically able to use the phone unassisted and complete questionnaires.
- Patient is assigned to a nurse case manager who has consented to participate in the research project
- Caregiver and patient intend to reside in the local area until the time of the patient's death
Exclusion Criteria:
- patient not being cared for by a partnering hospice
- patient without a histological diagnosis of cancer
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention Group
SCP-Hospice Alert
|
The intervention in Project 1 SCP utilizes a multi-faceted system.
The SCP-Hospice symptom management model will include several features: 1) a computer-based telecommunication system to monitor symptoms as perceived and reported by the family caregiver; 2) tailored care management messages that SCP provides directly to the caregivers to promote care management based on the individualized patient symptom profile and caregiver distress; and 3) an automated alerting function that notifies the hospice nurse of unrelieved symptoms that have exceeded a pre-set threshold.
|
|
Aucune intervention: Usual Care
Caregiver calls into monitoring system to report the patient's end of life symptoms but does not receive feedback about the symptoms and the hospice nurse does not receive the information.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Family Caregiver's Assessment of Dying Patient's Symptom Severity Level at End-of-Life
Délai: Changes in patient's end-of-life symptom levels are reported daily by the family caregiver from baseline (date of consent) until the patient's death or 6 months whichever occurs last.
|
Caregiver's report their assessment of the severity of patient's symptoms daily.
|
Changes in patient's end-of-life symptom levels are reported daily by the family caregiver from baseline (date of consent) until the patient's death or 6 months whichever occurs last.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Kathleen H Mooney, PhD, University of Utah
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 33122-SCP
- 1P01CA138317 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur SCP-Hospice Alert
-
Lonneke van de Poll-FranseComprehensive Cancer Centre The Netherlands; Dutch Cancer SocietyComplétéCancer des ovaires | Cancer de l'endomètrePays-Bas
-
University of PennsylvaniaNational Cancer Institute (NCI); American Cancer Society, Inc.ComplétéFibrose | Cancer de la tête et du cou | LymphœdèmeÉtats-Unis
-
Zuyderland Medisch CentrumAbbVieActif, ne recrute pasMaladie de ParkinsonPays-Bas
-
Allium, Ltd.ComplétéProlapsus des organes pelviens
-
Centre Hospitalier Universitaire de NiceComplété
-
The University of Texas at ArlingtonNational Institute on Aging (NIA)Complété
-
The University of Texas Medical Branch, GalvestonComplétéProlapsus des organes pelviensÉtats-Unis
-
Stanford UniversityComplétéThrombocytopénieÉtats-Unis
-
IrisZorgRadboud University Medical CenterRésilié
-
University Health Network, TorontoMcGill University Health Centre/Research Institute of the McGill University... et autres collaborateursComplété